Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2020-06-28 Report Publication Anno…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Datum:28.06.2020
Report Publication Announcement Classification · 100% confidence The document is a short notification (765 characters) informing shareholders that the annual financial report for the period 01.01.2019 to 31.12.2019 is available on the company's website. It does not contain the report itself, but rather acts as a formal announcement of its publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2020-06-28 German
aap Implantate AG: Postponement of publication of annual financial statements 2019 and annual general meeting 2020
Report Publication Announcement Classification · 100% confidence The document is a short news release dated April 29, 2020, announcing the postponement of two key events: the publication of the 2019 annual financial statements and the 2020 Annual General Meeting (AGM). It explicitly states that the exact date for the financial statement publication will be announced separately and that the AGM will be held at a later date. Because this document is an announcement *about* future reports and meetings, rather than the reports themselves (like a 10-K or the AGM materials), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically concerns the publication schedule of reports and meetings, RPA is a strong candidate, but since it is a general news item disseminated via DGAP (a regulatory news service) announcing delays, RNS (Regulatory Filings/General Regulatory Announcements) is often the appropriate catch-all for such non-standard updates that aren't explicitly ER, DIV, or DIRS. However, since it directly relates to the timing of the Annual Report and AGM, and it is a brief announcement, RPA is highly relevant. Given the context of DGAP dissemination and the nature of the announcement (postponement notice), RNS is the safest general regulatory classification, though RPA captures the intent of announcing a report's timing. I will classify it as RNS as it is a general regulatory news item disseminated via DGAP about corporate actions, which is the fallback for non-specific announcements.
2020-04-29 English
aap receives approval from ethics commissions for human clinical study for innovative antibacterial silver coating technology; all regulatory requirements for starting study in Germany fulfilled
Regulatory Filings Classification · 100% confidence The document is a news release dated April 23, 2020, disseminated via DGAP, which is a service for regulatory announcements and corporate news. The content announces that aap Implantate AG has received approval for a human clinical study for its antibacterial silver coating technology. This type of announcement, detailing a significant operational/regulatory milestone (approval from ethics commissions and BfArM) but not being a formal financial report (like 10-K, IR, or ER), fits best under the general category for regulatory announcements or corporate news that doesn't fit a more specific financial or governance code. Since it is a specific corporate update disseminated through a regulatory news service (DGAP), and it is not a financial report, a proxy statement, or an earnings release, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory announcement.
2020-04-23 English
aap Implantate AG resolves on concept for extensive staff reduction and extraordinary value adjustment to capitalized development costs; postponement of publication of the 2019 financial statements
Major Shareholding Notification Classification · 99% confidence The document is an 'Ad-hoc' announcement dated March 16, 2020, disclosing inside information according to MAR Regulation (EU) No 596/2014. The key content involves management decisions regarding staff reduction, an extraordinary value adjustment to capitalized development costs, and crucially, the *postponement of the publication of the 2019 financial statements* (both HGB and IFRS) until April 30, 2020. Since this document is an announcement about the status of financial reporting (postponement) rather than the full financial report itself (10-K or IR), and it is a formal regulatory disclosure, it fits best under the general 'Regulatory Filings' category (RNS) or potentially an 'Earnings Release' (ER) if it contained preliminary results. However, because it is primarily an announcement about corporate actions and the delay of the annual report, and not the actual earnings release or the annual report, RNS serves as the most appropriate general regulatory filing category for this type of ad-hoc disclosure that doesn't fit a more specific category like DIV, CAP, or MANG. It is not a Call Transcript (CT), Investor Presentation (IP), or Management Discussion & Analysis (MDA). Given the nature of the announcement (ad-hoc disclosure of material non-public information), RNS is the best fit as a catch-all for significant regulatory news.
2020-03-16 English
aap Implantate AG to present at German Equity Forum 2019
Regulatory Filings Classification · 99% confidence The document is a short news release dated November 21, 2019, announcing that aap Implantate AG will present at the German Equity Forum 2019 on November 26, 2019. It explicitly states that the accompanying presentation materials will be made available on the corporate website afterward. Because this document is an announcement about an upcoming presentation and the subsequent availability of presentation materials, rather than the presentation itself or a formal regulatory filing like a 10-K or ER, it fits best under the category of a general corporate announcement or a notice related to investor relations activities. Given the options, 'Investor Presentation' (IP) is for the presentation itself, and 'Report Publication Announcement' (RPA) is for announcing the release of a report. Since this is announcing participation in a conference where a presentation will be given, and the materials will follow, it is closely related to investor communication. However, the core content is an announcement about an event where an investor presentation will occur, and the materials will be posted later. This type of announcement, which is not a formal financial report but an update on investor engagement, often falls under general regulatory news or investor relations updates. Since the document is short and primarily serves to inform about a future event and the subsequent availability of materials, it aligns most closely with a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if we interpret the future presentation materials as the 'report'. Given the context of announcing participation in a conference, RNS (Regulatory Filings/General Announcements) is a strong candidate, but since it specifically mentions the presentation materials will be available, it is an announcement about investor materials. If the presentation materials were attached, it would be IP. Since it's just an announcement about the event and the future availability of materials, RNS is the safest general classification for non-standard announcements, or we could argue it's related to Investor Presentation (IP) materials being forthcoming. Given the options, and that it's a news release about an upcoming event where an investor presentation will be given, it is a general corporate news item. I will classify it as RNS as it is a general news dissemination via DGAP that doesn't fit the specific financial report codes.
2019-11-21 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') based on German Securities Trading Act (WpHG) sections (Art. 40, Sec. 1, Sec. 33, Sec. 34, Sec. 38). This structure perfectly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal disclosure of holding changes, not the results of a vote (DVA).
2019-11-19 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.